Heterocyclic ketones as inhibitors of histone deacetylase

被引：41
|
作者：
Vasudevan, A
Li, ZQ
Frey, RR
Wada, CK
Steinman, D
Heyman, HR
Guo, Y
Curtin, ML
Guo, J
Li, JL
Pease, L
Glaser, KB
Marcotte, PA
Bouska, JJ
Davidsen, SK
Michaelides, MR
机构：
[1] Abbott Labs, Med Chem Technol, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Canc Res, Abbott Pk, IL 60064 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 22期
关键词：
D O I：
10.1016/j.bmcl.2003.09.007
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Several heterocyclic ketones were investigated as potential inhibitors of histone deacetylase. Nanomolar inhibitors such as 22 and 25 were obtained, the anti-proliferative activity of which were shown to be mediated by HDAC inhibition. (C) 2003 Published by Elsevier Ltd.
引用
收藏
页码：3909 / 3913
页数：5
相关论文
共 50 条
  • [21] Histone deacetylase inhibitors in lymphoma
    Copeland, Amanda
    Buglio, Daniela
    Younes, Anas
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) : 431 - 436
  • [22] Pharmacogenomics and histone deacetylase inhibitors
    Goey, Andrew K. L.
    Sissung, Tristan M.
    Peer, Cody J.
    Figg, William D.
    PHARMACOGENOMICS, 2016, 17 (16) : 1807 - 1815
  • [23] Histone deacetylase inhibitors.
    Richon, VM
    Breslow, R
    Rifkind, RA
    Marks, PA
    CLINICAL CANCER RESEARCH, 2000, 6 : 4478S - 4478S
  • [24] Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
    Phimmachanh, Monica
    Han, Jeremy Z. R.
    O'Donnell, Yolande E., I
    Latham, Sharissa L.
    Croucher, David R.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [25] Histone deacetylase inhibitors and demethylating agents: Clinical development of histone deacetylase inhibitors for cancer therapy
    Piekarz, Richard L.
    Sackett, Dan L.
    Bates, Susan E.
    CANCER JOURNAL, 2007, 13 (01): : 30 - 39
  • [26] Synthesis of novel isoform selective histone deacetylase inhibitors containing chiral heterocyclic capping groups
    Matthews, Chris
    Marson, Charles
    Atkinson, Stephen
    Soden, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [27] Immunomodulatory Effects of Histone Deacetylase Inhibitors
    Licciardi, P. V.
    Ververis, K.
    Tang, M. L.
    El-Osta, A.
    Karagiannis, T. C.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (04) : 640 - 647
  • [28] Effects of histone deacetylase inhibitors on alloresponses
    Hancock, Wayne W.
    LANCET ONCOLOGY, 2014, 15 (01): : 10 - 11
  • [29] Dietary agents as histone deacetylase inhibitors
    Myzak, Melinda C.
    Ho, Emily
    Dashwood, Roderick H.
    MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 443 - 446
  • [30] Histone deacetylase inhibitors in cancer therapy
    Lee, Min-Jung
    Kim, Yeong Sang
    Kummar, Shivaani
    Giaccone, Giuseppe
    Trepel, Jane B.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 639 - 649
12345